Results 191 to 200 of about 238,371 (341)

NT-proBNP [PDF]

, 2019
openaire   +1 more source

Daratumumab plus bortezomib and dexamethasone (Dara‐VD) in newly diagnosed Mayo 2004 stage IIIA and IIIB light‐chain amyloidosis: Long‐term follow‐up results from a prospective phase 2 study

British Journal of Haematology, EarlyView.
Summary Anti‐CD38 monoclonal antibodies dramatically improve the prognosis in immunoglobulin light‐chain (AL) amyloidosis, yet patients with end‐stage (Mayo 2004 IIIB) disease are typically excluded from prospective trials. To evaluate the daratumumab plus bortezomib and dexamethasone (Dara‐VD) regimen in Mayo 2004 stage III patients, we conducted a ...
Gao Xue‐min, Xu Chengyang, Gao Ya‐juan, Guan Ai, Xu Yi, Chang Long, Shen Kai‐ni, Li Jian   +7 more
wiley   +1 more source

The significance of NT-proBNP decline in the evaluation of heart failure during maintenance hemodialysis

Linchuang shenzangbing zazhi, 2019
Objective To analyze the significance N-terminal pro-brain natriuretic peptide(NT-proBNP) decline in evaluation of heart failure during hemodialysis in patients with maintenance hemodialysis(MHD). Methods The level of NT-proBNP and ultrafiltration at 0 h,
LI Ping, YUAN Xiao-ying, XIAO Ying
doaj  

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

The "Dilution Effect" of Augmented Renal Clearance on the Prognostic Utility of NT-proBNP in Patients with Severe Traumatic Brain Injury. [PDF]

Int J Gen Med
Dong J, Zhang Q, Huang M, Zhou J, Zhou S, Zhu D.   +5 more
europepmc   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

British Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer, Daniel Finke, Sebastian Romann, Norbert Frey, Joerg Heineke, Lorenz H. Lehmann   +5 more
wiley   +1 more source

Impact of Predischarge NT-proBNP on Treatment Optimisation in Acute Heart Failure. [PDF]

Int J Mol Sci
Polovina M, Tomić M, Janković M, Civrić D, Stojićević A, Stanković S, Pejović T, Viduljević M, Krljanac G, Ašanin M, Stanković S, Seferović PM.   +11 more
europepmc   +1 more source

A comprehensive review of cancer‐induced cardiac wasting

British Journal of Pharmacology, EarlyView.
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena, Muhammad Shahzeb Khan, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Markus S. Anker   +5 more
wiley   +1 more source

NT-proBNP as a Predictive and Prognostic Biomarker for Complications in Hypertensive Pregnancy Disorders. [PDF]

J Clin Med
Mocuta D, Aur C, Zaha IA, Cseppento CDN, Sachelarie L, Huniadi A.   +5 more
europepmc   +1 more source

Dynamics of NT-proBNP in Pregnancy

JACC: Advances, 2023
Amy A. Sarma, Nandita S. Scott
openaire   +1 more source